Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zacks Small-Cap Core Fund Institutional Class (ZSCIX)

28.49
Net Asset Value
+0.04%
1 Day
+2.04%
Year-to-Date
Overall Morningstar Rating
Small blend
Style or Category
No Load
Sales Expenses
1.41%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund pursues its investment objective by applying a hybrid research process which uses both quantitative and qualitative criteria. It will invest at least 80% of its net assets (including amounts borrowed for investment purposes) in a diversified portfolio of equity securities of small capitalization companies, with an emphasis on equity securities of U.S. issuers. The fund may engage in short-sale transactions up to 25% of its net assets. It also may invest in equity securities of Canadian issuers and American Depository Receipts.

Performance

1 month+4.17% 3 years--
3 months+7.65% 5 years--
1 year+36.22% Since inception+8.08%
Data through --

Peer Comparisonvs. Small blend

 ZSCIXCategory
Performance 5-yr return--+13.52%
Expense ratio1.41%1.23%
Risk 5 year sharpe ratio1.050.90
Net assets$126.6M$977.4M
Average market cap$1.1B$3.0B
Average P/E23.922.4
Portfolio turnover147%147%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyZacks Funds
Fund manager & tenureBenjamin Zacks / 5 Years
Minimal initial investment$5,000.00
Minimum IRA investment$2,000.00

Holdings

U.S. stock100.06%
Cash1.44%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
UCBI United Community Banks Inc2.45%
BANF BancFirst Corp2.21%
NUTR Nutraceutical International Corp2.20%
BUSE First Busey Corp2.13%
SCL Stepan Co2.09%
SPTN SpartanNash Co2.08%
NSIT Insight Enterprises Inc2.08%
IPHS Innophos Holdings Inc2.06%
NP Neenah Paper Inc2.02%
ICUI ICU Medical Inc2.01%